PubRank

E C Holmes

Author PubWeight™ 248.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004 10.21
2 Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993 8.07
3 Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A 2001 7.90
4 Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 2001 6.51
5 Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993 6.41
6 The epidemic behavior of the hepatitis C virus. Science 2001 4.81
7 Evolutionary aspects of recombination in RNA viruses. J Gen Virol 1999 3.74
8 Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A 1996 3.69
9 Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 1968 3.56
10 Extinction rates can be estimated from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci 1994 3.47
11 Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992 3.37
12 Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993 2.87
13 Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A 2006 2.77
14 Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology 2002 2.53
15 Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 1994 2.53
16 Ecology and evolution of rabies virus in Europe. J Gen Virol 1999 2.52
17 Causes of HIV diversity. Nature 1995 2.48
18 Inferring population history from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci 1995 2.21
19 A likelihood method for the detection of selection and recombination using nucleotide sequences. Mol Biol Evol 1997 2.20
20 Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature 2001 2.20
21 Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA 1993 2.17
22 BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg 1974 2.14
23 Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A 1999 2.12
24 Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol 1999 2.10
25 The role of MCM proteins in the cell cycle control of genome duplication. Bioessays 1996 2.09
26 The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 1991 2.06
27 Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 1995 2.00
28 Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994 1.95
29 Parathyroid carcinoma: a collective review. Ann Surg 1969 1.94
30 Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 1999 1.93
31 A rational approach to the surgical management of melanoma. Ann Surg 1977 1.88
32 Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res 1997 1.84
33 A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission. Arch Virol 2005 1.72
34 Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs. Virus Res 1997 1.63
35 Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol 2003 1.61
36 Epidemic dynamics revealed in dengue evolution. Mol Biol Evol 2009 1.58
37 The molecular evolution of the alcohol dehydrogenase and alcohol dehydrogenase-related genes in the Drosophila melanogaster species subgroup. Mol Biol Evol 1994 1.58
38 Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med 1976 1.57
39 Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol 2005 1.55
40 Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995 1.54
41 Genetic diversity of Borrelia burgdorferi sensu lato in ticks from mainland Portugal. J Clin Microbiol 2000 1.50
42 In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol 1994 1.50
43 Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J Gen Virol 2001 1.48
44 Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol 1996 1.46
45 A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J Virol 1996 1.44
46 Population dynamics of HIV-1 inferred from gene sequences. Genetics 1999 1.43
47 A phylogenetic survey of recombination frequency in plant RNA viruses. Arch Virol 2005 1.39
48 Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett 2001 1.37
49 Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene 1995 1.34
50 Genetic analysis of Israel acute paralysis virus: distinct clusters are circulating in the United States. J Virol 2008 1.34
51 Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control 1991 1.34
52 Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol 2001 1.32
53 Evidence for the non-quasispecies evolution of RNA viruses [corrected]. Mol Biol Evol 2001 1.31
54 Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J Gen Virol 1997 1.28
55 Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg 2000 1.28
56 Immune and artificial selection in the haemagglutinin (H) glycoprotein of measles virus. J Gen Virol 2001 1.26
57 Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol 2001 1.25
58 Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Res 1995 1.24
59 Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol 1993 1.24
60 Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 1993 1.23
61 Primer Master: a new program for the design and analysis of PCR primers. Comput Appl Biosci 1996 1.23
62 Biological consequences of deletions within the 3'-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res 1999 1.22
63 New inferences from tree shape: numbers of missing taxa and population growth rates. Syst Biol 2002 1.22
64 Pulmonary resection for metastatic sarcoma. Am J Surg 1980 1.22
65 Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics 2006 1.20
66 Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994 1.18
67 Evolution, epidemiology, and dispersal of flaviviruses revealed by molecular phylogenies. Adv Virus Res 2001 1.17
68 Sequence data as evidence. Nature 1993 1.17
69 The evolutionary dynamics of canid and mongoose rabies virus in Southern Africa. Arch Virol 2007 1.17
70 Recombination between sequences of hepatitis B virus from different genotypes. J Mol Evol 1996 1.12
71 Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg 1995 1.11
72 Pseudomembranous colitis associated with cephazolin therapy. Am J Surg 1977 1.10
73 Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes. J Virol 2000 1.08
74 Regional lymph node metastases and the level of invasion of primary melanoma. Cancer 1976 1.08
75 Evolution of base composition and codon usage bias in the genus Flavivirus. J Mol Evol 2001 1.07
76 Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000. Ann Thorac Surg 2001 1.07
77 Geographic and species association of hepatitis B virus genotypes in non-human primates. Virology 2003 1.06
78 The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery 1978 1.05
79 Immunotherapy of malignancy in humans. Current status. JAMA 1975 1.05
80 Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group. Cancer 1984 1.04
81 Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium. Cancer Res 1976 1.04
82 Reconstructing the complex evolutionary history of hepatitis B virus. J Mol Evol 1999 1.03
83 Homologous recombination in GB virus C/hepatitis G virus. Mol Biol Evol 2001 1.03
84 Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy. J Gen Virol 1994 1.02
85 The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg 1996 1.01
86 Variation in the number of expressed MHC genes in different cattle class I haplotypes. Immunogenetics 1999 1.01
87 Muscle-sparing posterolateral thoracotomy. Ann Thorac Surg 1988 1.01
88 Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo. Immunology 1989 1.00
89 The mid-depth method and HIV-1: a practical approach for testing hypotheses of viral epidemic history. Mol Biol Evol 1999 1.00
90 Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000 1.00
91 Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene 1993 0.99
92 Inhibition of human leukocyte migration in agarose by kcl extracts of carcinoma of the lung. Int J Cancer 1975 0.99
93 Immunotherapy experiments with a methylcholanthrene-induced guinea pig liposarcoma. J Natl Cancer Inst 1971 0.99
94 Rupture of dissecting aneurysm of thoracic aorta into the right heart chambers. J Thorac Cardiovasc Surg 1974 0.99
95 Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts. J Virol 2006 0.98
96 Pulmonary resection for sarcoma metastases. Orthop Clin North Am 1977 0.97
97 Genome sequence analysis of Tamana bat virus and its relationship with the genus Flavivirus. J Gen Virol 2002 0.97
98 Tracing the origins of louping ill virus by molecular phylogenetic analysis. J Gen Virol 1998 0.96
99 In vitro detection of guinea pig alloantigens by the macrophage-inhibition technique. Transplantation 1969 0.96
100 Preliminary results of a randomized trial of adjuvant immunotherapy in patients with malignant melanoma who have lymph node metastases. Aust N Z J Surg 1978 0.95
101 Molecular epidemiology of dengue virus--the time for big science. Trop Med Int Health 1998 0.94
102 Immunology of tumor infiltrating lymphocytes. Ann Surg 1985 0.94
103 Soluble tumor-specific transplantation antigens from methylcholanthrene-induced guinea pig sarcomas. Cancer 1970 0.94
104 Starch granulomatous peritonitis. Surgery 1972 0.93
105 Insufficiency of the native aortic valve and left ventricular assist system inflow valve after support with an implantable left ventricular assist system: signs, symptoms, and concerns. J Thorac Cardiovasc Surg 2001 0.93
106 Purification and immunologic evaluation of human melnoma-associated antigens. J Natl Cancer Inst 1978 0.93
107 At least four MHC class I genes are transcribed in the horse: phylogenetic analysis suggests an unusual evolutionary history for the MHC in this species. Eur J Immunogenet 1995 0.93
108 Detection of antibodies against the mammary tumor virus with the antiglobulin consumption test. J Natl Cancer Inst 1969 0.90
109 BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma. Med Clin North Am 1976 0.90
110 Biopsy of thoracic neoplasms for assay of chemosensitivity. New indication for thoracotomy. Arch Surg 1983 0.90
111 Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 1986 0.89
112 Acute hepatitis C infection after sexual exposure. Gut 1995 0.89
113 Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res 1985 0.89
114 Genetic drift of human immunodeficiency virus type 1? J Virol 1998 0.89
115 The evolutionary dynamics of influenza A virus adaptation to mammalian hosts. Philos Trans R Soc Lond B Biol Sci 2013 0.88
116 Surgical treatment and chemotherapy for pulmonary metastases from osteosarcoma. Arch Surg 1992 0.88
117 Role of pulmonary vascular resistance measurements in preoperative evaluation of candidates for pulmonary resection. J Thorac Cardiovasc Surg 1978 0.87
118 Surgical management and reconstruction of extensive chest wall malignancies. Am J Surg 1982 0.87
119 The genetic diversification of the HIV type 1 gag p17 gene in patients infected from a common source. AIDS Res Hum Retroviruses 1995 0.87
120 Zucchini yellow mosaic virus (ZYMV, Potyvirus): vertical transmission, seed infection and cryptic infections. Virus Res 2013 0.87
121 Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung Cancer Study Group. J Cancer Res Clin Oncol 1999 0.87
122 Immunologic aspects of lung cancer. Chest 1977 0.86
123 The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin. Mod Pathol 1994 0.86
124 Interleukin-1 and tumor necrosis factor production by tumor-associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients. Int J Cancer 1988 0.86
125 Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group. Oncogene 1990 0.86
126 Factors affecting survival in superior sulcus tumors. J Clin Oncol 1986 0.85
127 Immunologic defects in lung cancer patients. J Thorac Cardiovasc Surg 1976 0.85
128 Immunology and lung cancer. Ann Thorac Surg 1976 0.85
129 Lymphocyte responses of lung cancer patients to tumor-associated antigen measured by leucine incorporation. J Thorac Cardiovasc Surg 1975 0.85
130 In vitro assessment of antineoplastic therapy. New indication for thoracotomy? J Thorac Cardiovasc Surg 1981 0.84
131 Mediastinal masses: magnetic resonance imaging in comparison with computed tomography. J Natl Med Assoc 1991 0.84
132 Altered lymphatic drainage following lymphadenectomy. Cancer 1980 0.84
133 Intralesional BCG immunotherapy of pulmonary tumors. J Thorac Cardiovasc Surg 1979 0.84
134 Approaches for the isolation of biologically functional tumor-associated antigens. Cancer Res 1977 0.84
135 Aneurysm of the sinus of Valsalva resulting from bacterial endocarditis. Ann Thorac Surg 1973 0.83
136 The CD45 locus in cattle: allelic polymorphism and evidence for exceptional positive natural selection. Immunogenetics 2001 0.83
137 Purification of soluble human melanoma-associated antigens. Cancer Res 1976 0.83
138 Lymphoid cells infiltrating human pulmonary tumors: effect of intralesional BCG injection. J Natl Cancer Inst 1981 0.82
139 TNF-alpha and IFN-gamma reverse IL-4 inhibition of lymphokine-activated killer cell function. Cell Immunol 1990 0.82
140 Serum-mediated immunosuppression in lung cancer. Cancer 1979 0.82
141 Inhibition of leukocyte migration in agarose by KCl extracts of human melanoma cell line grown in serum-free medium. Int J Cancer 1975 0.82
142 Cross-reacting tumor-specific transplantation antigens in methylcholanthrene-induced guinea pig sarcomas. J Natl Cancer Inst 1971 0.82
143 Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma. Am J Surg 1976 0.81
144 Uroscopy in the 21st century: high-field NMR spectroscopy. Nephrol Dial Transplant 1997 0.81
145 Membrane antigens detected on human lung carcinoma cells by hybridoma monoclonal antibody. J Surg Res 1981 0.81
146 Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol 1995 0.81
147 Serum-mediated immunosuppression in cancer. Surg Forum 1977 0.81
148 Management of primary germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg 1982 0.80
149 Deep sequencing reveals persistence of intra- and inter-host genetic diversity in natural and greenhouse populations of zucchini yellow mosaic virus. J Gen Virol 2012 0.80
150 Isolation of a soluble tumor-associated antigen from human melanoma. Cancer 1976 0.80
151 Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg 1996 0.80
152 HIV clearance in an infant? Nature 1995 0.80
153 Molecular variation, evolution and geographical distribution of louping ill virus. Acta Virol 1997 0.79
154 Segmental configuration and putative origin of the reassortant orbivirus, epizootic hemorrhagic disease virus serotype 6, strain Indiana. Virology 2012 0.79
155 Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes. Cancer Res 1988 0.79
156 Resection of pulmonary metastases from nonseminomatous testicular tumors. Correlation of clinical and histological features with treatment outcome. Cancer 1983 0.79
157 Capillary tube leukocyte adherence inhibition: an assay for cell-mediated immunity in cancer patients. Int J Cancer 1976 0.79
158 Model phylogenies to explain the real world. Bioessays 1994 0.79
159 Testing the extent of sequence similarity among viroids, satellite RNAs, and hepatitis delta virus. J Mol Evol 2000 0.79
160 Pericardiectomy for radiation-induced pericarditis with effusion. Ann Thorac Surg 1969 0.78
161 Modification of natural killer activity of lymphocytes infiltrating human lung cancers. Cancer Immunol Immunother 1987 0.78
162 Rejection of dinitrochlorobenzene-conjugated syngeneic tumor cells by dinitrochlorobenzene-sensitized guinea pigs. J Surg Res 1978 0.78
163 The surgical management of pulmonary metastases. Semin Oncol 1977 0.78
164 The role of thoracic surgery in the management of metastatic osteogenic sarcoma. Chest Surg Clin N Am 1994 0.78
165 Serum enzyme alterations after extensive surgical procedures. Ann Surg 1969 0.77
166 New method of immunotherapy for lung cancer. Lancet 1977 0.77
167 Further characterization of 2 types of precore variant hepatitis B virus isolates from Hong Kong. J Infect Dis 1995 0.77
168 Monoclonal antibodies to human malignant mesothelioma. J Clin Immunol 1987 0.77
169 Mitoxantrone for malignant pleural effusion due to metastatic sarcoma. Surg Oncol 1993 0.77
170 A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group. Ann Surg 1985 0.77
171 Water soluble guinea pig transplantation antigen from carcinogen-induced sarcomas. J Immunol 1969 0.76
172 Phylogenetic analysis of multiple heterosexual transmission events involving subtype b of HIV type 1. AIDS Res Hum Retroviruses 2001 0.76
173 Immunotherapy of cancer. West J Med 1977 0.75
174 Immune adjuvant therapy in lung cancer. Prog Exp Tumor Res 1980 0.75
175 Effect of bacillus Calmette-Guerin immunotherapy on tumor antigen-induced lymphocyte-stimulated protein synthesis in melanoma patients. Surgery 1975 0.75
176 Surgical results and surgical adjuvant therapy for lung cancer. Am J Surg 1982 0.75
177 Hybridoma monoclonal antibody: use in defining surface antigens on human lung carcinoma cells. Transplant Proc 1981 0.75
178 Cellular immunity to tumor-associated antigens in sarcoma patients and their relatives. Surg Forum 1975 0.75
179 Immunology of lung cancer. Chest 1977 0.75
180 Decreased correlation between the agarose leukocyte migration inhibition assay and delayed cutaneous hypersensitivity response to purified protein derivative in cancer patients. J Natl Cancer Inst 1978 0.75
181 Isolated pulmonary nodules in head and neck cancer patients. Ann Otol Rhinol Laryngol 1989 0.75
182 Demonstration by the antiglobulin consumption test with murine antisera of common antigens in tissues infected with the mammary tumor virus from different mouse strains. J Natl Cancer Inst 1971 0.75
183 In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy. J Thorac Cardiovasc Surg 1977 0.75
184 Immunotherapy of solid tumor. Surg Clin North Am 1979 0.75
185 Preoperative neoadjuvant therapy in non-small-cell lung cancer: open season? J Natl Cancer Inst 1991 0.75
186 Surgical adjuvant therapy for lung cancer. Surg Clin North Am 1981 0.75
187 Surgical adjuvant therapy of non-small cell lung cancer. Chest 1986 0.75
188 Non-small cell lung cancer. Curr Probl Cancer 1987 0.75
189 A method for improved yield and purity in extracting lymphocytes from lung tumors. J Surg Res 1985 0.75
190 Thoracotomy in the management of metastatic soft-tissue sarcomas in adults. Chest Surg Clin N Am 1994 0.75
191 Delayed cutaneous hypersensitivity reactions to melanoma antigen. Surgery 1975 0.75
192 Treatment of stage II lung cancer (T1N1 and T2N1). Surg Clin North Am 1987 0.75
193 Parotid duct transplantation for correction of drooling in patients with cancer of the head and neck. Surg Gynecol Obstet 1971 0.75
194 Inhibition of human leukocyte migration in agarose by KC1 extracts of lung cancer. Surg Forum 1974 0.75
195 Non-small cell lung cancer. Dis Mon 1988 0.75
196 Adenosquamous carcinoma and the biology of lung cancer. Ann Thorac Surg 1987 0.75
197 Transverse tarsal navicular fracture. A case report. J Am Podiatr Med Assoc 1986 0.75
198 Current status of adjuvant chemotherapy in the treatment of non-small cell lung cancer. Important Adv Oncol 1988 0.75
199 Intralesional BCG injection of pulmonary neoplasms: radiographic findings. AJR Am J Roentgenol 1981 0.75
200 Immunopathological features of human pulmonary tumors following low-dose interleukin-2. Cancer Immunol Immunother 1991 0.75
201 Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes. Am J Respir Cell Mol Biol 1993 0.75
202 Differential regulation by interleukin-4 and interferon-gamma of an autologous melanoma-specific cytotoxic T-cell clone and the tumor-infiltrating lymphocytes from which it was established. Cancer Commun 1990 0.75
203 Surgical adjuvant therapy of non-small-cell lung cancer. Cancer Treat Res 1989 0.75
204 Immunotherapy as an adjunct to surgery in the treatment of cancer. World J Surg 1977 0.75
205 Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer. Cancer Immunol Immunother 1982 0.75
206 Immunotherapy of malignancies: current status. AJR Am J Roentgenol 1976 0.75
207 Delayed cutaneous hypersensitivity to cell-free tumor antigens. Cancer Res 1973 0.75
208 BCG immunotherapy of lung cancer. Jpn J Surg 1980 0.75